Related Experiment Video
Updated: Apr 19, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
p21-Activated kinase 5 affects cisplatin-induced apoptosis and proliferation in hepatocellular carcinoma cells
Ding-Guo Zhang1, Jinling Zhang, Lin-Lin Mao
1Jiangsu Key Laboratory of Biological Cancer Therapy, Xuzhou Medical College, 84 West Huai-hai Road, Xuzhou, 221002, China.
Abstract:
p21-Activated kinase 5 (PAK5) is the last identified member of the PAK family. The PAKs are highly conserved serine/threonine and effector proteins for Cdc42 and Rac and are essential in regulating cell motility and survival. Previous studies have demonstrated that PAK5 played a pivotal role in apoptosis, proliferation, cancer migration, and invasion. However, the biological function of PAK5 in hepatocellular carcinoma, as well as its underlying mechanism, still remains to be fully elucidated. In the present study, we demonstrated that PAK5 markedly inhibited cisplatin-induced apoptosis and promoted cell proliferation in hepatocellular carcinoma cells. Moreover, our results showed that overexpression of PAK5 contributed to cell cycle regulation. In order to elucidate the underlying mechanism of PAK5 on cisplatin-induced apoptosis and cell cycle regulation, we also examined the protein expressions of chk2 and p-chk2. In summary, our study investigated the role of PAK5 in cisplatin-induced cellular processes and provided evidence of its underlying mechanism.
Insights
p21-Activated kinase 5 (PAK5) inhibits apoptosis and promotes proliferation in liver cancer cells. This study investigates PAK5
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- p21-Activated kinase 5 (PAK5) is a key regulator of cell motility and survival.
- PAK5 has been implicated in apoptosis, proliferation, cancer migration, and invasion.
- The specific role and mechanism of PAK5 in hepatocellular carcinoma remain unclear.
Purpose of the Study:
- To investigate the function of PAK5 in hepatocellular carcinoma (HCC).
- To elucidate the underlying molecular mechanisms of PAK5 in HCC.
- To determine PAK5's role in cisplatin-induced apoptosis and cell cycle regulation in HCC.
Main Methods:
- Investigated PAK5's effect on cisplatin-induced apoptosis in HCC cells.
- Assessed PAK5's impact on HCC cell proliferation.
- Examined PAK5's role in cell cycle regulation.
- Analyzed the expression of chk2 and p-chk2 proteins to understand the mechanism.
Main Results:
- PAK5 significantly inhibited cisplatin-induced apoptosis in HCC cells.
- Overexpression of PAK5 promoted HCC cell proliferation.
- PAK5 was found to contribute to cell cycle regulation in HCC.
- Changes in chk2 and p-chk2 protein expression were observed in relation to PAK5 activity.
Conclusions:
- PAK5 plays a crucial role in regulating cisplatin-induced apoptosis and cell proliferation in hepatocellular carcinoma.
- PAK5 influences cell cycle regulation in HCC.
- The study provides insights into the molecular mechanisms underlying PAK5's function in HCC, involving chk2 and p-chk2 pathways.
Related Concept Videos
Inhibition of Cdk Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
The Intrinsic Apoptotic Pathway

